|
Volumn 16, Issue 12, 2014, Pages 1638-1646
|
Organic cation transporter variation and response to smoking cessation therapies
a a a b b b a b a a a b a b b |
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZAZEPINE DERIVATIVE;
ORGANIC CATION TRANSPORTER;
QUINOXALINE DERIVATIVE;
SLC22A2 PROTEIN, HUMAN;
VARENICLINE;
ADULT;
CONTROLLED STUDY;
FEMALE;
GENETIC VARIABILITY;
GENETICS;
HUMAN;
MALE;
MIDDLE AGED;
PROCEDURES;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
SINGLE NUCLEOTIDE POLYMORPHISM;
SMOKING;
SMOKING CESSATION;
TOBACCO USE DISORDER;
ADULT;
BENZAZEPINES;
FEMALE;
GENETIC VARIATION;
HUMANS;
MALE;
MIDDLE AGED;
ORGANIC CATION TRANSPORT PROTEINS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
PROSPECTIVE STUDIES;
QUINOXALINES;
SMOKING;
SMOKING CESSATION;
TOBACCO USE DISORDER;
VARENICLINE;
|
EID: 84964698891
PISSN: None
EISSN: 1469994X
Source Type: Journal
DOI: 10.1093/ntr/ntu161 Document Type: Article |
Times cited : (20)
|
References (0)
|